Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0040425 (tonsillitis)
1,594 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The prevalence of mycosis affecting ears, nose, and throat was analysed based on the literature data and the results of original observations of 3964 patients who applied for medical aid to the counseling department of our centre during the period from 2005 to 2007. The study revealed a relative increase in the occurrence of ear, nose, and throat mycosis in the structure of chronic inflammatory pathology. Specifically, the frequency of mycotic otitis rose to 25.2%, mycotic infestation of the pharynx in patients with pharyngitis and tonsillitis to 28.7%, mycotic infestation of the larynx associated with chronic laryngitis to 20%, and mycosis in patients presenting with chronic inflammation of the nasal cavity or paranasal sinuses to 7%. The spectrum of pathogenic fungi affecting ears, nose, and throat has been identified. The enhanced contribution of various non-albicans Candida strains to the development of chronic inflammation is documented. Aspergillus species are shown to play the increasingly more important role in the affection of palatal tonsils, laryngeal and pharyngeal mucosa.
...
PMID:[Selected aspects of modern epidemiology of ENT-mycoses]. 2151 77

The analysis of the prevalence of mycoses based on the literature data and original observations gives evidence of the increase in the relative frequency of mycotic lesions in the overall ENT morbidity. The occurrence of otomycosis among otitides of different etiology is estimated at 25% and that of pharyngomycosis in the patients presenting with chronic pharygitis and tonsillitis up to 28%. The mycotic lesions in the larynx are diagnosed in almost 15% of the patients with chronic laryngitis. Chronic inflammation of intranasal cavity and paranasal sinuses is associated with mycosis in 7% of the patients. The factors that promote the development of mycotic lesions are considered and specific clinical manifestations described with special reference to their localization and taxonomical identification of the fungi. The optimal approaches to the diagnostics and treatment of ENT mycosis are discussed. The strategies of local and general antimycotic therapy are proposed with the use of modern antimycotic agents taking into account peculiarities of the clinical course of the disease, indications and contraindications for their application.
...
PMID:[The modern approach to diagnostics and treatment of mycotic lesions in ear, nose, and throat]. 2326 56

The objective of the present study was to estimate the effectiveness and safety of the treatment of exacerbations of chronic tonsillitis with zitrolid forte given during 3 days. This antibiotic was prescribed to the patients presenting with a confirmed inflammatory process of coccal etiology less than 3 days in duration. The effectiveness of zitrolid was evaluated based on the results of dynamic clinical studies, laboratory analysis, and pharyngoscopic data. The study has demonstrated the effectiveness and safety of zitrolid forte as a medicine for empirical therapy of tonsillitis and exacerbations of chronic laryngitis.
...
PMID:[On the problem of rational antibacterial therapy of inflammatory diseases of the upper respiratory tract]. 2326 57